×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Exicure Inc. (XCUR) NASDAQ

$0.66 0.04 (5.64%)

Market Cap: $5.36M

As of 02/28/24 03:58 PM EST. Market closed.

(XCUR)

Exicure Inc. (XCUR)
NASDAQ

$0.66
0.04 (5.64%)

Market Cap: $5.36M

As of 02/28/24 03:58 PM EST. Market closed.

Add to Portfolio

exicure, formerly aurasense therapeutics, is developing a new class of immunomodulatory and gene silencing drugs against validated targets. our 3-dimensional, spherical nucleic acid (sna™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. our lead programs address diseases from inflammatory disorders to oncology. sna constructs overcome one of the most ... read more

exicure, formerly aurasense therapeutics, is developing a new class of immunomodulatory and gene silencing drugs against validated targets. our 3-dimensional, spherical nucleic acid (sna™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs. our lead programs address diseases from inflammatory disorders to oncology. sna constructs overcome one of the most difficult obstacles to nucleic acid therapeutics: safe and effective delivery into cells and tissues. sna constructs exhibit unparalleled transfection efficiency into numerous cell and tissue types including the skin without carriers or transfection agents. moreover, snas can be used as potent immunotherapeutic agents for the treatment of cancer or infectious disease. read less

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
David Giljohann
Full Time Employees
38
URL
Address
8045 Lamon Ave Ste 410, Illinois, Skokie, 60077-5318.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
David Giljohann
Full Time Employees
38
Address
8045 Lamon Ave Ste 410, Illinois, Skokie, 60077-5318.
PRICE CHART FOR EXICURE INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.68
Previous Close
$0.62
Days Range
$0.62 - $0.68
52 week range
$0.36 - $1.50
Volume
87,549
Avg. Volume (30 days)
604,309
Market Cap
$5.36M
Dividend Yield
-
P/E
1.75
Shares Outstanding
8,648,307
Open
$0.68
Previous Close
$0.62
Days Range
$0.62 - $0.68
52 week range
$0.36 - $1.50
Volume
87,549
Avg. Volume (30 days)
604,309
Market Cap
$5.36M
Dividend Yield
-
P/E
1.75
Shares Outstanding
8,648,307
FINANCIAL STATEMENTS FOR EXICURE INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR EXICURE INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Miller JoshChief Accounting OfficerNov 16, 2023 Option Exercise$0.5638211,873Dec 01, 2023, 06:14 PM
Miller JoshChief Accounting OfficerAug 16, 2023 Option Exercise$0.8337311,911Aug 18, 2023, 06:09 PM
CBI USA, Inc.10% OwnerJun 23, 2023 Option Exercise$1.603,400,0005,440,000818,299Jun 27, 2023, 06:20 PM
Miller JoshChief Accounting OfficerMay 16, 2023 Option Exercise$1.071851981,948May 25, 2023, 02:19 PM
CBI USA, Inc.10% OwnerDec 15, 2022 Buy$1.603,400,0005,440,0004,218,299Dec 19, 2022, 04:54 PM
Muralidhar BaliDirectorMay 19, 2022 Buy$0.191,472,126285,1518,449,126May 19, 2022, 04:50 PM
Gates Frontier, LLC10% OwnerDec 21, 2021 Sale$0.241,268,619303,2005,064,703Dec 22, 2021, 04:13 PM
Giljohann David AChief Executive OfficerNov 15, 2021 Option Exercise$0.917,5006,82538,666Nov 23, 2021, 04:46 PM
Feltner Douglas E.Chief Medical OfficerNov 15, 2021 Option Exercise$0.917,5006,82515,000Nov 23, 2021, 04:45 PM
Papadimas Elias D.Chief Accounting OfficerAug 27, 2021 Buy$1.3810,00013,80010,000Sep 08, 2021, 07:00 AM
Feltner Douglas E.Chief Medical OfficerMay 14, 2021 Option Exercise$1.277,5009,5257,500May 20, 2021, 06:30 PM
Venkatesan JayDirectorJul 06, 2020 Option Exercise$0.8722,24019,369324,473Jul 08, 2020, 04:46 PM
AURASENSE LLC10% OwnerJun 12, 2020 Sale$2.8310,19528,85211,257,629Jun 16, 2020, 09:43 PM
Mirkin Chad A.DirectorJun 12, 2020 Sale$2.8310,19528,85211,257,629Jun 16, 2020, 09:35 PM
Mirkin Chad A.DirectorMay 20, 2020 Option Exercise$0.6549,64932,27264,649May 21, 2020, 04:46 PM
WALT DAVID RDirectorMar 13, 2020 Buy$1.21291,066352,8592,058,777Mar 16, 2020, 08:47 AM
SNYDER DAVID SChief Financial OfficerMar 12, 2020 Buy$1.4018,24825,59118,248Mar 16, 2020, 08:46 AM
Mirkin Chad A.DirectorMar 12, 2020 Buy$1.4515,00021,75015,000Mar 16, 2020, 08:46 AM
Muralidhar BaliDirectorDec 19, 2019 Buy$2.75727,0001,999,2506,977,000Dec 23, 2019, 04:05 PM
Mirkin Chad A.DirectorAug 02, 2019 Buy$2.0025,00050,00025,000Aug 06, 2019, 05:13 PM
Venkatesan JayDirectorAug 02, 2019 Buy$2.00250,000500,000302,234Aug 06, 2019, 05:11 PM
WALT DAVID RDirectorAug 02, 2019 Buy$2.001,000,0002,000,0001,767,711Aug 06, 2019, 05:09 PM
Mirkin Chad A.DirectorMar 22, 2019 Buy$2.305001,15027,267Mar 22, 2019, 04:12 PM
Mirkin Chad A.DirectorMar 21, 2019 Buy$2.431,0002,43026,767Mar 21, 2019, 04:41 PM
Giljohann David AChief Executive OfficerMar 19, 2019 Buy$2.407,00016,80023,666Mar 19, 2019, 04:52 PM
Mirkin Chad A.DirectorMar 18, 2019 Buy$2.401,0002,40025,767Mar 18, 2019, 05:21 PM
Mirkin Chad A.DirectorMar 13, 2019 Buy$2.502,2005,50024,767Mar 14, 2019, 04:58 PM
WALT DAVID RDirectorSep 26, 2017 Buy$3.00268,333804,999767,711Sep 28, 2017, 09:43 PM
Giljohann David AChief Executive OfficerSep 26, 2017 Buy$3.0016,66649,99816,666Sep 28, 2017, 09:42 PM
Venkatesan JayDirectorSep 26, 2017 Buy$3.0066,666199,998156,858Sep 28, 2017, 09:40 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Miller JoshChief Accounting Officer11/16/202321
Miller JoshChief Accounting Officer08/16/202331
CBI USA, Inc.10% Owner06/23/20235,440,000
Miller JoshChief Accounting Officer05/16/2023198
CBI USA, Inc.10% Owner12/15/20225,440,000
Muralidhar BaliDirector05/19/2022285,151
Gates Frontier, LLC10% Owner12/21/2021303,200
Giljohann David AChief Executive Officer11/15/20216,825
Feltner Douglas E.Chief Medical Officer11/15/20216,825
Papadimas Elias D.Chief Accounting Officer08/27/202113,800
Feltner Douglas E.Chief Medical Officer05/14/20219,525
Venkatesan JayDirector07/06/202019,369
AURASENSE LLC10% Owner06/12/202028,852
Mirkin Chad A.Director06/12/202028,852
Mirkin Chad A.Director05/20/202032,272
WALT DAVID RDirector03/13/2020352,859
SNYDER DAVID SChief Financial Officer03/12/202025,591
Mirkin Chad A.Director03/12/202021,750
Muralidhar BaliDirector12/19/20191,999,250
Mirkin Chad A.Director08/02/201950,000
Venkatesan JayDirector08/02/2019500,000
WALT DAVID RDirector08/02/20192,000,000
Mirkin Chad A.Director03/22/20191,150
Mirkin Chad A.Director03/21/20192,430
Giljohann David AChief Executive Officer03/19/201916,800
Mirkin Chad A.Director03/18/20192,400
Mirkin Chad A.Director03/13/20195,500
WALT DAVID RDirector09/26/2017804,999
Giljohann David AChief Executive Officer09/26/201749,998
Venkatesan JayDirector09/26/2017199,998
Load More Insider Transactions
FUNDS WITH A POSITION IN EXICURE INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC49,5000.00004%-14.66%Other
GEODE CAPITAL MANAGEMENT, LLC52,9960%No changeOther
BLACKROCK INC.5,1250%-58.58%Other
BUYBACK ANNOUNCEMENT(S) FOR EXICURE INC
LOADING...